3v9v

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:3v9v.jpg|left|200px]]
+
[[Image:3v9v.png|left|200px]]
-
<!--
 
-
The line below this paragraph, containing "STRUCTURE_3v9v", creates the "Structure Box" on the page.
 
-
You may change the PDB parameter (which sets the PDB file loaded into the applet)
 
-
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
 
-
or leave the SCENE parameter empty for the default display.
 
-
-->
 
{{STRUCTURE_3v9v| PDB=3v9v | SCENE= }}
{{STRUCTURE_3v9v| PDB=3v9v | SCENE= }}
===Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator===
===Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator===
- 
-
<!--
 
-
The line below this paragraph, {{ABSTRACT_PUBMED_22225641}}, adds the Publication Abstract to the page
 
-
(as it appears on PubMed at http://www.pubmed.gov), where 22225641 is the PubMed ID number.
 
-
-->
 
{{ABSTRACT_PUBMED_22225641}}
{{ABSTRACT_PUBMED_22225641}}

Revision as of 10:21, 8 August 2012

Template:STRUCTURE 3v9v

Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator

Template:ABSTRACT PUBMED 22225641

About this Structure

3v9v is a 2 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

  • Furukawa A, Arita T, Fukuzaki T, Satoh S, Mori M, Honda T, Matsui Y, Wakabayashi K, Hayashi S, Araki K, Ohsumi J. Substituents at the naphthalene C3 position of (-)-Cercosporamide derivatives significantly affect the maximal efficacy as PPARgamma partial agonists. Bioorg Med Chem Lett. 2012 Feb 1;22(3):1348-51. Epub 2011 Dec 16. PMID:22225641 doi:10.1016/j.bmcl.2011.12.066

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools